Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Citi
Medtronic
US Department of Justice
Cipla
Boehringer Ingelheim
Baxter
Chinese Patent Office
Deloitte
McKesson

Generated: July 19, 2018

DrugPatentWatch Database Preview

Haloprogin - Generic Drug Details

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

What are the generic sources for haloprogin and what is the scope of haloprogin freedom to operate?

Haloprogin
is the generic ingredient in one branded drug marketed by Westwood Squibb and is included in two NDAs. Additional information is available in the individual branded drug profile pages.

There is one drug master file entry for haloprogin.
Summary for haloprogin
US Patents:0
Tradenames:1
Applicants:1
NDAs:2
Drug Master File Entries: 1
Bulk Api Vendors: 21
Patent Applications: 2,641
DailyMed Link:haloprogin at DailyMed
Synonyms for haloprogin
(3-Iod-2-propinyl)-(2,4,5-trichlorphenyl)ether
1,2,4-Trichloro-5-(3-iodo-prop-2-ynyloxy)-benzene
1,2,4-trichloro-5-(3-iodoprop-2-ynoxy)benzene
1,2,4-trichloro-5-(3-iodoprop-2-ynyloxy)benzene
1,2,4-trichloro-5-[(3-iodo-2-propynyl) oxy]benzene
1,2,4-trichloro-5-[(3-iodoprop-2-yn-1-yl)oxy]benzene
2,4,5-Trichlorophenyl .gamma.-iodopropargil ether
2,4,5-Trichlorophenyl .gamma.-iodopropargyl ether
2,4,5-Trichlorophenyl gamma-iodopropargil ether
2,4,5-Trichlorophenyl iodopropargyl ether
2,4,5-Trichlorophenyl-gamma-iodopropargyl ether
2,5-Trichlorophenyl .gamma.-iodopropargil ether
2,5-Trichlorophenyl .gamma.-iodopropargyl ether
2,5-Trichlorophenyl iodopropargyl ether
3-Iodo-2-propynyl 2,4,5-trichlorophenyl ether
3-Iodo-2-propynyl 2,5-trichlorophenyl ether
777-11-7
777H117
AC1L1G7Q
AC1Q3I91
AIU7053OWL
AKOS030627167
aloprogen
AN-47592
API0008981
BDBM50194601
Benzene, 1,2,4-trichloro-5-((3-iodo-2-propynyl)oxy)-
Benzene, 1,2,4-trichloro-5-[(3-iodo-2-propynyl)oxy]-
Benzene,1,2,4-trichloro-5-[(3-iodo-2-propynyl)oxy]
Benzene,2,4-trichloro-5-[(3-iodo-2-propynyl)oxy]-
BRD-K13238168-001-01-2
BRN 1976771
C9H4Cl3IO
CAS-777-11-7
CCG-220402
CHEBI:5614
CHEBI:94512
CHEMBL1289
component of Halotex
CTETYYAZBPJBHE-UHFFFAOYSA-N
D00339
D06ZAY
DB00793
DivK1c_000762
DSSTox_CID_26865
DSSTox_GSID_46865
DSSTox_RID_81972
DTXSID9046865
EINECS 212-286-6
Ether, 3-iodo-2-propynyl 2,4,5-trichlorophenyl
Ether,4,5-trichlorophenyl
FCH1325214
Haloprogen
Haloprogin (JAN/USAN/INN)
Haloprogin [USAN:INN:JAN]
Haloprogina
Haloprogina [INN-Spanish]
Haloprogine
Haloprogine [INN-French]
Haloproginum
Haloproginum [INN-Latin]
Halotex
Halotex (Salt/Mix)
Halotex (TN)
HMS502G04
IDI1_000762
KBio1_000762
KBio2_002365
KBio2_004933
KBio2_007501
KBioSS_002369
LS-67855
M 1028
M-1028 (Meiji)
Mycanden
Mycanden (TN)
Mycilan
Mycilan (TN)
NCGC00181134-01
NCGC00181134-02
NINDS_000762
NSC 100071
NSC-100071
NSC100071
OR070134
OR340497
Polik
Polik (TN)
Prestwick_232
SCHEMBL3649
Spectrum_001852
Tox21_112741
UNII-AIU7053OWL
WLN: I1UU2OR BG DG EG
Z3201
ZINC1530649

US Patents and Regulatory Information for haloprogin

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Westwood Squibb HALOTEX haloprogin SOLUTION;TOPICAL 016943-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Westwood Squibb HALOTEX haloprogin CREAM;TOPICAL 016942-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
Medtronic
Chubb
Cerilliant
Cantor Fitzgerald
Baxter
Cipla
US Department of Justice
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.